Changes in the Neuronal Architecture of the Hippocampus in a 6-Hydroxydopamine-Lesioned Rat Model of Parkinson Disease

Overview

Journal Int Neurourol J

Date 2022 Dec 12

PMID 36503212

Authors

Bohye Kim

Poornima D E Weerasinghe-Mudiyanselage

Mary Jasmin Ang

Jeongmin Lee

Sohi Kang

Jong-Choon Kim

Sung-Ho Kim

Joong-Sun Kim

Chaeyong Jung

Taekyun Shin

Changjong Moon

Affiliations

Soon will be listed here.

Abstract

Purpose: Parkinson disease (PD) is a progressive neurodegenerative disorder in which dopaminergic (DAergic) systems are destroyed (particularly in the nigrostriatal system), causing both motor and nonmotor symptoms. Hippocampal neuroplasticity is altered in PD animal models, resulting in nonmotor dysfunctions. However, little is known about the precise mechanism underlying the hippocampal dysfunctions in PD.

Methods: Striatal 6-hydroxydopamine (6-OHDA) infusions were performed unilaterally in adult Sprague Dawley rats. Both motor and nonmotor symptoms alongside the expression of tyrosine hydroxylase (TH) in the substantia nigra and striatum were confirmed in 6-OHDA-lesioned rats. The neuronal architecture in the hippocampus was analyzed by Golgi staining.

Results: During the 7-8 weeks after infusion, the 6-OHDA-lesioned rats exhibited motor and nonmotor dysfunctions (especially anxiety/depression-like behaviors). Rats with unilateral 6-OHDA infusion displayed reduced TH+ immunoreactivity in the ipsilateral nigrostriatal pathway of the brain. Golgi staining revealed that striatal 6-OHDA infusion significantly decreased the dendritic complexity (i.e., number of crossing dendrites, total dendritic length, and branch points) in the ipsilateral hippocampal conus ammonis 1 (CA1) apical/basal and dentate gyrus (DG) subregions. Additionally, the dendritic spine density and morphology were significantly altered in the CA1 apical/basal and DG subregions following striatal 6-OHDA infusion. However, alteration of microglial and astrocytic distributions did not occur in the hippocampus following striatal 6-OHDA infusion.

Conclusion: The present study provides anatomical evidence that the structural plasticity in the hippocampus is altered in the late phase following striatal 6-OHDA infusion in rats, possibly as a result of the prolonged suppression of the DAergic system, and independent of neuroinflammation.

Citing Articles

Challenges and Opportunities in Exploring Non-Motor Symptoms in 6-Hydroxydopamine Models of Parkinson's Disease: A Systematic Review.

Prates-Rodrigues M, Schweizer B, de Paula Gomes C, Ribeiro A, Padovan-Neto F, Masini D J Neurochem. 2025; 169(2):e70008.

PMID: 39901598 PMC: 11791392. DOI: 10.1111/jnc.70008.

Identifying candidate genes associated with hippocampal dysfunction in a hemiparkinsonian rat model by transcriptomic profiling.

Kim B, Hong S, Lee J, Kang S, Kim J, Jung C Anim Cells Syst (Seoul). 2024; 28(1):198-215.

PMID: 38693920 PMC: 11062273. DOI: 10.1080/19768354.2024.2348671.

Changes in structural plasticity of hippocampal neurons in an animal model of multiple sclerosis.

Weerasinghe-Mudiyanselage P, Kang S, Kim J, Kim S, Wang H, Shin T Zool Res. 2024; 45(2):398-414.

PMID: 38485508 PMC: 11017077. DOI: 10.24272/j.issn.2095-8137.2023.309.

Dopamine depletion alters neuroplasticity-related signaling in the rat hippocampus.

Kim B, Kim J, Youn B, Moon C Anim Cells Syst (Seoul). 2023; 27(1):436-446.

PMID: 38125760 PMC: 10732217. DOI: 10.1080/19768354.2023.2294308.

Understanding the spectrum of non-motor symptoms in multiple sclerosis: insights from animal models.

Weerasinghe-Mudiyanselage P, Kim J, Shin T, Moon C Neural Regen Res. 2023; 19(1):84-91.

PMID: 37488849 PMC: 10479859. DOI: 10.4103/1673-5374.375307.

References

Su R, Zhen J, Wang W, Zhang J, Zheng Y, Wang X . Time-course behavioral features are correlated with Parkinson's disease‑associated pathology in a 6-hydroxydopamine hemiparkinsonian rat model. Mol Med Rep. 2017; 17(2):3356-3363. PMC: 5783532. DOI: 10.3892/mmr.2017.8277. View

Weerasinghe-Mudiyanselage P, Ang M, Kang S, Kim J, Moon C . Structural Plasticity of the Hippocampus in Neurodegenerative Diseases. Int J Mol Sci. 2022; 23(6). PMC: 8955928. DOI: 10.3390/ijms23063349. View

Sy H, Wu S, Wang W, Chen C, Huang Y, Liou Y . MPTP-induced dopaminergic degeneration and deficits in object recognition in rats are accompanied by neuroinflammation in the hippocampus. Pharmacol Biochem Behav. 2010; 95(2):158-65. DOI: 10.1016/j.pbb.2009.12.020. View

. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018; 18(1):88-106. PMC: 6291454. DOI: 10.1016/S1474-4422(18)30403-4. View

Ang M, Kang S, Moon C . Melatonin alters neuronal architecture and increases cysteine-rich protein 1 signaling in the male mouse hippocampus. J Neurosci Res. 2020; 98(11):2333-2348. DOI: 10.1002/jnr.24708. View

Schaefers A, Teuchert-Noodt G . Developmental neuroplasticity and the origin of neurodegenerative diseases. World J Biol Psychiatry. 2013; 17(8):587-599. DOI: 10.3109/15622975.2013.797104. View

Weerasinghe-Mudiyanselage P, Ang M, Wada M, Kim S, Shin T, Yang M . Acute MPTP Treatment Impairs Dendritic Spine Density in the Mouse Hippocampus. Brain Sci. 2021; 11(7). PMC: 8301854. DOI: 10.3390/brainsci11070833. View

Borgkvist A, Malmlof T, Feltmann K, Lindskog M, Schilstrom B . Dopamine in the hippocampus is cleared by the norepinephrine transporter. Int J Neuropsychopharmacol. 2011; 15(4):531-40. DOI: 10.1017/S1461145711000812. View

Dheen S, Kaur C, Ling E . Microglial activation and its implications in the brain diseases. Curr Med Chem. 2007; 14(11):1189-97. DOI: 10.2174/092986707780597961. View

10.

Sepulveda B, Mesias R, Li X, Yue Z, Benson D . Short- and long-term effects of LRRK2 on axon and dendrite growth. PLoS One. 2013; 8(4):e61986. PMC: 3640004. DOI: 10.1371/journal.pone.0061986. View

11.

Janakiraman U, Manivasagam T, Thenmozhi A, Essa M, Barathidasan R, SaravanaBabu C . Influences of Chronic Mild Stress Exposure on Motor, Non-Motor Impairments and Neurochemical Variables in Specific Brain Areas of MPTP/Probenecid Induced Neurotoxicity in Mice. PLoS One. 2016; 11(1):e0146671. PMC: 4713092. DOI: 10.1371/journal.pone.0146671. View

12.

Yoon D, Yoon S, Kim D, Kim H, Baik J . Regulation of dopamine D2 receptor-mediated extracellular signal-regulated kinase signaling and spine formation by GABAA receptors in hippocampal neurons. Neurosci Lett. 2014; 586:24-30. DOI: 10.1016/j.neulet.2014.12.010. View

13.

Verkhratsky A, Rodriguez J, Parpura V . Astroglia in neurological diseases. Future Neurol. 2013; 8(2):149-158. PMC: 3645493. DOI: 10.2217/fnl.12.90. View

14.

Koyama Y, Hattori T, Nishida T, Hori O, Tohyama M . Alterations in dendrite and spine morphology of cortical pyramidal neurons in DISC1-binding zinc finger protein (DBZ) knockout mice. Front Neuroanat. 2015; 9:52. PMC: 4415407. DOI: 10.3389/fnana.2015.00052. View

15.

Esmaeili-Mahani S, Haghparast E, Nezhadi A, Abbasnejad M, Sheibani V . Apelin-13 prevents hippocampal synaptic plasticity impairment in Parkinsonism rats. J Chem Neuroanat. 2020; 111:101884. DOI: 10.1016/j.jchemneu.2020.101884. View

16.

Grealish S, Mattsson B, Draxler P, Bjorklund A . Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson's disease. Eur J Neurosci. 2010; 31(12):2266-78. DOI: 10.1111/j.1460-9568.2010.07265.x. View

17.

Calabresi P, Castrioto A, Di Filippo M, Picconi B . New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease. Lancet Neurol. 2013; 12(8):811-21. DOI: 10.1016/S1474-4422(13)70118-2. View

18.

Cheung Y, Lim S, Ho H, Chan A . Cytokines as mediators of chemotherapy-associated cognitive changes: current evidence, limitations and directions for future research. PLoS One. 2013; 8(12):e81234. PMC: 3855252. DOI: 10.1371/journal.pone.0081234. View

19.

Kang S, Lee S, Kim J, Kim J, Kim S, Son Y . Chronic Treatment with Combined Chemotherapeutic Agents Affects Hippocampal Micromorphometry and Function in Mice, Independently of Neuroinflammation. Exp Neurobiol. 2018; 27(5):419-436. PMC: 6221841. DOI: 10.5607/en.2018.27.5.419. View

20.

Guatteo E, Berretta N, Monda V, Ledonne A, Mercuri N . Pathophysiological Features of Nigral Dopaminergic Neurons in Animal Models of Parkinson's Disease. Int J Mol Sci. 2022; 23(9). PMC: 9102081. DOI: 10.3390/ijms23094508. View